• US: +1 9176726599
  • Login

Artificial Organ and Bionics Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Format: PDF | Pages: 308 | Report ID: MRS1131


Report Description

The global Artificial Organ and Bionics market size is estimated at USD 24,008.4 Million in 2020, expanding at a CAGR of 10.1% from 2021 to 2027 to reach 31,400.8 Million USD in 2027.

Market Dynamics

Diabetes is one of the most common causes of chronic kidney disease (CKD) and the leading cause of kidney failure, according to a 2019 report from the Centers for Disease Control and Prevention. According to the report's data, the percentage of adults with diabetes who have advanced stage CKD (stage 3 or 4) increased from 19.5 percent in 1999–2004 to 24.5 percent in 2011–2014. Furthermore, the prevalence of diabetes is rising.

When the kidneys fail, hemodialysis is used to remove waste products such as creatinine and urea, as well as free water, from the blood. The artificial kidney cleans the patient's blood. As a result, an artificial kidney is also known as a dialysis machine. Dialysis is a vital bodily function that involves the filtration and excretion of metabolic waste products, the regulation of essential electrolytes and fluids, and the stimulation of red blood cell production. As a result, as the prevalence of kidney failure rises, so will the demand for artificial kidneys.

Regional Insights

North America currently dominates the market for artificial organs and bionics and is expected to do so for the foreseeable future. The United States has the largest market share in North America. The rising prevalence of chronic diseases, as well as the increased demand for non-invasive surgical procedures, are contributing to the North American region's dominance in the artificial organs and bionics market. The presence of well-developed healthcare infrastructure is also expected to drive the market forward.

Segment Insights

The Artificial Organ and Bionics market is fragmented into type, and technology segments. Based on the type, the artificial organ segment is anticipated to dominate the market. Based on technology, mechanical bionics dominates the market in the forecast period.

Competitive Insights

The majority of artificial organs and bionics are produced by global key players. Market leaders have established their market position by investing more in research and developing a better distribution system. Furthermore, as awareness grows, some small players are emerging in Asia-Pacific. This has also aided the market's expansion.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Artificial organs and Bionics by type, technology, and region. In addition, this report introduces the market competition situation among the vendors, and the company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):

  • ABIOMED, INC
  • Berlin Heart GmbH
  • Biomet, Inc
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Cochlear, LTD
  • Edward Lifesciences Corporations
  • Ekso Bionics
  • Heartware International, Inc
  • Iwalk, Inc.
  • Jarvik Heart, Inc
  • SynCardia Systems, Inc
  • Medtronic, Inc
  • Orthofix International N.V
  • Ossur
  • Jude Medical, Inc.
  • Second Sight Medical Products, Inc.
  • Baxter International, Inc.
  • Asahi Kasei Medical Co., Ltd
  • F Hoffman – La Roche Ltd

Type Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

      • Artificial Organs
        • Artificial Heart
        • Artificial Kidney
        • Artificial Lungs
        • Cochlear Implants
        • Other Organ Types
      • Bionics
        • Vision Bionics
        • Ear Bionics
        • Orthopedic Bionics
        • Cardiac Bionics

Technology Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Electronic Bionics
  • Mechanical Bionics

Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa, etc.)

Frequently Asked Questions

The global Artificial Organ and Bionics market size is estimated at USD 24,008.4 Million in 2020, expanding at a CAGR of 10.1% from 2021 to 2027 to reach 31,400.8 Million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Artificial Organ and Bionics market size is expanding at a CAGR of 10.1% from 2021 to 2027 to reach 31,400.8 Million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The majority of artificial organs and bionics are produced by global key players. Market leaders have established their market position by investing more in research and developing a better distribution system. Furthermore, as awareness grows, some small players are emerging in Asia-Pacific. This has also aided the market's expansion.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.